Literature DB >> 33316779

Comprehensive analysis of immune infiltration and gene expression for predicting survival in patients with sarcomas.

Hongmin Chen1,2, Yijiang Song1,2, Chuangzhong Deng1,2, Yanyang Xu1,2, Huaiyuan Xu1,2, Xiaojun Zhu1,2, Guohui Song1,2, Qinglian Tang1,2, Jinchang Lu1,2, Jin Wang1,2.   

Abstract

Tumor microenvironments are strongly related to tumor development, and immune-infiltrating cells and immune-related molecules are potential prognostic markers. However, the shortcomings of traditional measurement methods limit the accurate evaluation of various components in tumor microenvironments. With the rapid advancement of Next-Generation RNA Sequencing technology, dedicated and in-depth analyses of immune filtration within the tumor microenvironment has been achieved. In this study, we combined the bioinformatics analysis methods ESTIMATE, CIBERSORT, and ssGSEA to characterize the immune infiltration of sarcomas and to identify specific immunomodulators of different pathological subtypes. We further extracted a functional enrichment of significant immune-related genes related to improved prognosis, including NR1H3, VAMP5, GIMAP2, GBP2, HLA-E and CRIP1. Overall, the immune microenvironment is an important prognostic determinant of sarcomas and may be a potential resource for developing effective immunotherapy.

Entities:  

Keywords:  immune checkpoint; sarcoma; tumor-infiltrating immune cells

Mesh:

Substances:

Year:  2020        PMID: 33316779      PMCID: PMC7880383          DOI: 10.18632/aging.202229

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  47 in total

1.  APC mutations in synovial sarcoma.

Authors:  Tsuyoshi Saito; Yoshinao Oda; Akio Sakamoto; Ken-ichi Kawaguchi; Kazuhiro Tanaka; Shuichi Matsuda; Sadafumi Tamiya; Yukihide Iwamoto; Masazumi Tsuneyoshi
Journal:  J Pathol       Date:  2002-04       Impact factor: 7.996

2.  Human leucocyte antigen class I and class II antigen expression in malignant fibrous histiocytoma, fibrosarcoma and dermatofibrosarcoma protuberans is significantly downregulated.

Authors:  M Meissner; V König; I Hrgovic; E Valesky; R Kaufmann
Journal:  J Eur Acad Dermatol Venereol       Date:  2010-11       Impact factor: 6.166

3.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

4.  Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study.

Authors:  Eytan Ben-Ami; Constance M Barysauskas; Sarah Solomon; Kadija Tahlil; Rita Malley; Melissa Hohos; Kathleen Polson; Margaret Loucks; Mariano Severgnini; Tara Patel; Amy Cunningham; Scott J Rodig; F Stephen Hodi; Jeffrey A Morgan; Priscilla Merriam; Andrew J Wagner; Geoffrey I Shapiro; Suzanne George
Journal:  Cancer       Date:  2017-04-25       Impact factor: 6.860

Review 5.  Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy.

Authors:  J M Pitt; A Marabelle; A Eggermont; J-C Soria; G Kroemer; L Zitvogel
Journal:  Ann Oncol       Date:  2016-04-10       Impact factor: 32.976

6.  Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors.

Authors:  Melinda S Merchant; Matthew Wright; Kristin Baird; Leonard H Wexler; Carlos Rodriguez-Galindo; Donna Bernstein; Cindy Delbrook; Maya Lodish; Rachel Bishop; Jedd D Wolchok; Howard Streicher; Crystal L Mackall
Journal:  Clin Cancer Res       Date:  2015-11-03       Impact factor: 12.531

7.  CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer.

Authors:  Chunyan Gu-Trantien; Edoardo Migliori; Laurence Buisseret; Alexandre de Wind; Sylvain Brohée; Soizic Garaud; Grégory Noël; Vu Luan Dang Chi; Jean-Nicolas Lodewyckx; Céline Naveaux; Hugues Duvillier; Stanislas Goriely; Denis Larsimont; Karen Willard-Gallo
Journal:  JCI Insight       Date:  2017-06-02

8.  Immune Checkpoint Profiles in Luminal B Breast Cancer (Alliance).

Authors:  Meenakshi Anurag; Mayanne Zhu; Chen Huang; Suhas Vasaikar; Junkai Wang; Jeremy Hoog; Samantha Burugu; Dongxia Gao; Vera Suman; Xiang H Zhang; Bing Zhang; Torsten Nielsen; Matthew J Ellis
Journal:  J Natl Cancer Inst       Date:  2020-07-01       Impact factor: 13.506

9.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

10.  High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohort.

Authors:  Gillian Mitchell; Mandy L Ballinger; Stephen Wong; Chelsee Hewitt; Paul James; Mary-Anne Young; Arcadi Cipponi; Tiffany Pang; David L Goode; Alex Dobrovic; David M Thomas
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

View more
  1 in total

1.  Retinoic Acid Metabolism-Related Enzyme Signature Identified Prognostic and Immune Characteristics in Sarcoma.

Authors:  HuaiYuan Xu; JinXin Hu; YiJiang Song; HongMin Chen; YanYang Xu; ChuangZhong Deng; Hao Wu; GuoHui Song; JinChang Lu; QinLian Tang; LiangPing Xia; Jin Wang; XiaoJun Zhu
Journal:  Front Cell Dev Biol       Date:  2022-02-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.